Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TLSA	TIZIANA LIFE SCIENCES LTD	$175.94M	-924.30%	-161.80%	-6,444.41%	1,249.60%	220.06	0.76	N/A	N/A	N/A
XWEL	XWELL INC	$12.24M	N/A	-169.80%	-140.95%	-205.00%	38.34	2.35	29.60%	-118.40%	-81.18%
MDAI	SPECTRAL AI INC	$84.02M	N/A	-78.80%	362.42%	423.10%	-3.01	0.75	46.00%	-82.00%	-75.74%
IMUX	IMMUNIC INC	$167.54M	-220.70%	-132.00%	-68.89%	407.30%	0.26	4.92	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.06B	-52.20%	-43.90%	-43.94%	-54.40%	0.37	9.29	N/A	N/A	N/A
VRDN	VIRIDIAN THERAPEUTICS INC	$1.82B	-60.70%	-50.60%	-47.85%	-65.40%	0.24	15.15	100.00%	-508.50%	-497.44%
NBP	NOVABRIDGE BIOSCIENCES	$205.48M	-20.90%	-19.40%	-19.80%	-73.60%	0.13	8.09	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$2.75B	-15.10%	-14.40%	-11.70%	-21.30%	0.04	26.16	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$339.31M	-57.00%	-51.50%	-75.24%	-81.10%	0.14	7.89	N/A	N/A	N/A
ALMS	ALUMIS INC	$2.83B	-54.60%	-43.50%	-40.95%	-67.30%	0.18	7.51	100.00%	-2,825.70%	-2,927.59%
CGON	CG ONCOLOGY INC	$5.70B	-23.30%	-22.20%	-16.98%	-24.20%	0.04	31.30	-50.00%	-3,682.60%	-3,682.61%
PVLA	PALVELLA THERAPEUTICS INC	$1.66B	-56.90%	-42.50%	-16.46%	-633.60%	0.14	28.88	N/A	N/A	N/A
ZLAB	ZAI LAB LTD	$2.15B	-24.30%	-15.50%	-24.75%	-138.50%	0.66	2.40	57.90%	-39.30%	-38.37%
SENS	SENSEONICS HOLDINGS INC	$231.59M	-130.00%	-67.20%	-107.76%	-71.70%	2.00	3.51	52.10%	-214.20%	-202.58%
VANI	VIVANI MEDICAL INC	$100.03M	-264.00%	-79.80%	-76.13%	-86.20%	1.22	3.18	N/A	N/A	N/A
WGS	GENEDX HOLDINGS CORP	$1.41B	-27.50%	-15.70%	-17.88%	-28.10%	0.99	3.09	69.60%	-17.60%	-16.91%
TSHA	TAYSHA GENE THERAPIES INC	$1.59B	-56.10%	-40.20%	-46.32%	-220.10%	0.42	14.04	100.00%	-1,738.40%	-1,737.69%
SABS	SAB BIOTHERAPEUTICS INC	$291.33M	-0.30%	-0.30%	-0.07%	-0.10%	0.09	11.45	N/A	N/A	N/A
KRRO	KORRO BIO INC	$161.53M	-117.90%	-71.00%	-66.79%	-73.30%	0.54	8.13	100.00%	-2,954.10%	-2,935.09%
SPRY	ARS PHARMACEUTICALS INC	$817.27M	-153.60%	-60.80%	-81.11%	-52.70%	3.69	4.94	74.10%	-200.00%	-194.99%
FBRX	FORTE BIOSCIENCES INC	$450.53M	-106.20%	-85.50%	-170.84%	641.40%	0.60	2.75	N/A	N/A	N/A
PRCT	PROCEPT BIOROBOTICS CORP	$1.65B	-27.70%	-20.30%	-26.18%	-45.70%	0.40	6.73	64.00%	-31.80%	-34.43%
ACB	AURORA CANNABIS INC	$201.89M	-20.60%	-14.00%	-15.21%	-17.60%	0.39	3.06	34.50%	-30.20%	-25.65%
IMVT	IMMUNOVANT INC	$7.01B	-68.20%	-62.20%	-59.28%	4,013.20%	0.12	9.09	N/A	N/A	N/A
PASG	PASSAGE BIO INC	$16.55M	-150.90%	-59.80%	-230.32%	-270.70%	2.10	1.73	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$368.96k	-207.50%	-100.70%	-80.17%	383.20%	0.35	3.79	N/A	N/A	N/A
ORGO	ORGANOGENESIS HOLDINGS INC	$342.27M	-7.20%	-3.60%	0.67%	0.80%	0.57	3.53	72.90%	-3.60%	0.58%
OLMA	OLEMA PHARMACEUTICALS INC	$1.23B	-45.90%	-41.20%	-38.30%	-51.00%	0.10	10.88	N/A	N/A	N/A
NGNE	NEUROGENE INC	$436.29M	-37.90%	-34.70%	-40.38%	-52.40%	0.11	13.08	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$32.68B	-83.20%	-59.10%	-67.98%	-65.20%	0.50	6.80	N/A	N/A	N/A
HUMA	HUMACYTE INC	$226.46M	-2,781.60%	-85.40%	-92.26%	-80.30%	8.51	3.93	-475.00%	-4,840.80%	-4,318.95%
PHGE	BIOMX INC	$7.50M	-917.60%	-344.00%	-7,670.65%	-597.60%	-4.69	1.24	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$5.23B	-49.20%	-46.40%	-28.59%	-70.10%	0.04	27.79	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$1.10B	-38.90%	-35.70%	-18.32%	-44.40%	0.05	19.81	N/A	N/A	N/A
STXS	STEREOTAXIS INC	$185.70M	-258.10%	-47.60%	-70.07%	-207.70%	2.40	1.56	53.90%	-73.60%	-69.50%
LITS	LITE STRATEGY INC	$37.43M	-90.80%	-89.30%	-107.01%	-108.90%	0.02	11.53	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$5.72B	-163.50%	-96.70%	-84.39%	-216.20%	0.94	8.64	N/A	N/A	N/A
CLPT	CLEARPOINT NEURO INC	$350.88M	-141.00%	-37.00%	-30.08%	-37.70%	3.96	5.79	62.30%	-71.60%	-62.17%
IRD	OPUS GENETICS INC	$349.19M	N/A	-223.00%	-185.80%	1,046.20%	-1.92	7.13	100.00%	-892.40%	-890.71%
CRBP	CORBUS PHARMACEUTICALS HOLDINGS INC	$213.25M	-70.90%	-61.80%	-66.90%	-88.60%	0.14	7.92	N/A	N/A	N/A
ENGN	ENGENE THERAPEUTICS INC	$115.89M	-55.80%	-45.70%	-38.23%	-51.90%	0.20	11.75	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.56B	-36.90%	-33.90%	-33.06%	-39.40%	0.09	24.00	N/A	N/A	N/A
PHIO	PHIO PHARMACEUTICALS CORP	$12.66M	-77.30%	-70.90%	-66.41%	1,458.10%	0.06	18.32	N/A	N/A	N/A
SNSE	SENSEI BIOTHERAPEUTICS INC	$23.56M	N/A	-256.50%	-96.47%	-879.10%	-0.10	14.39	N/A	N/A	N/A
CAPR	CAPRICOR THERAPEUTICS INC	$1.71B	-59.30%	-48.60%	-38.12%	-105.00%	0.17	8.42	N/A	N/A	N/A
CRNX	CRINETICS PHARMACEUTICALS INC	$3.91B	-44.00%	-39.60%	-37.30%	-43.80%	0.09	18.60	92.90%	-2,747.20%	-2,746.18%
ZBIO	ZENAS BIOPHARMA INC	$1.25B	-167.70%	-97.40%	-59.88%	-161.80%	1.23	11.94	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$421.79M	-76.80%	-65.90%	-34.39%	568.20%	0.05	19.33	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$77.96M	-127.30%	-34.50%	-47.72%	-32.10%	3.44	1.65	100.00%	-4,088.80%	-4,088.84%
ABEO	ABEONA THERAPEUTICS INC	$314.61M	41.40%	29.50%	41.69%	57.30%	0.37	5.89	70.90%	454.90%	480.13%
RNAC	CARTESIAN THERAPEUTICS INC	$196.27M	N/A	-45.90%	-59.08%	-107.40%	-2.95	7.65	100.00%	-8,698.70%	-9,068.56%
VALN	VALNEVA SE	$509.34M	-106.20%	-32.60%	-34.77%	-27.10%	3.85	2.14	29.50%	-88.30%	-61.79%
MGX	METAGENOMI THERAPEUTICS INC	$49.32M	-51.20%	-36.60%	-49.32%	-40.60%	0.43	6.43	100.00%	-384.60%	-385.27%
ZNTL	ZENTALIS PHARMACEUTICALS INC	$294.71M	-53.60%	-40.70%	-56.73%	-46.50%	0.39	6.19	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$431.03M	-102.70%	-72.20%	-108.40%	-88.80%	0.58	5.60	N/A	N/A	N/A
EDSA	EDESA BIOTECH INC	$96.66M	-82.30%	-75.40%	-102.41%	1,789.60%	0.22	4.76	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$97.30M	-238.00%	-151.00%	-66.81%	761.30%	0.11	9.92	N/A	N/A	N/A
RPID	RAPID MICRO BIOSYSTEMS INC	$95.57M	-131.50%	-67.50%	-112.71%	-84.20%	2.06	2.58	2.90%	-145.80%	-141.75%
MIST	MILESTONE PHARMACEUTICALS INC	$189.24M	-339.40%	-61.80%	-35.49%	-52.90%	4.37	9.18	99.20%	-3,832.00%	-3,437.50%
HOTH	HOTH THERAPEUTICS INC	$12.24M	-165.20%	-143.60%	-280.82%	-3,991.50%	0.34	3.39	N/A	N/A	N/A
RARE	ULTRAGENYX PHARMACEUTICAL INC	$2.34B	N/A	-45.70%	-62.33%	-38.20%	-6.28	2.02	83.50%	-90.90%	-90.37%
FLGT	FULGENT GENETICS INC	$493.60M	-6.70%	-6.20%	-7.78%	-9.10%	0.11	5.32	38.70%	-23.00%	-25.90%
SDGR	SCHRODINGER INC	$988.56M	-30.80%	-15.30%	-21.99%	-26.40%	1.02	2.74	55.30%	-40.60%	-40.08%
RNXT	RENOVORX INC	$39.78M	-138.60%	-104.60%	-101.87%	2,924.70%	0.24	7.15	78.70%	-824.00%	-823.98%
SLDB	SOLID BIOSCIENCES INC	$639.92M	-74.50%	-62.00%	-48.85%	-120.70%	0.13	13.10	N/A	N/A	N/A
STEX	STREAMEX CORP	$117.83M	-719.70%	-337.20%	-290.97%	1,449.50%	0.09	13.90	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$1.43B	-866.50%	-138.00%	-156.05%	-152.70%	2.60	7.41	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$755.92M	-47.20%	-38.80%	-27.32%	-305.80%	0.14	20.52	N/A	N/A	N/A
PRME	PRIME MEDICINE INC	$532.82M	-188.80%	-61.00%	-76.76%	-60.10%	2.84	3.80	100.00%	-4,917.60%	-4,917.55%
DMAC	DIAMEDICA THERAPEUTICS INC	$310.91M	-77.20%	-69.30%	-74.22%	-90.40%	0.12	9.11	N/A	N/A	N/A
IVVD	INVIVYD INC	$327.01M	-53.50%	-41.60%	-36.94%	-396.90%	0.19	6.47	92.90%	-138.90%	-138.90%
MDWD	MEDIWOUND LTD	$216.14M	-65.80%	-30.20%	-35.10%	-60.20%	0.98	2.33	19.20%	-140.80%	-125.30%
ORIC	ORIC PHARMACEUTICALS INC	$875.76M	-35.30%	-33.30%	-32.27%	-41.00%	0.05	16.33	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$439.16M	-128.60%	-46.30%	-54.09%	-32.90%	3.84	5.80	-11.20%	-312.00%	-270.67%
VNDA	VANDA PHARMACEUTICALS INC	$373.44M	-61.40%	-44.60%	-50.25%	-65.50%	0.54	2.16	94.20%	-110.00%	-68.74%
MDXH	MDXHEALTH SA	$4.24M	N/A	-22.00%	-6.82%	-5.90%	-8.95	1.63	63.80%	-29.90%	-7.33%
OSTX	OS THERAPIES INC	$81.06M	N/A	-422.40%	364.62%	417.70%	-1.58	0.05	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$300.26M	-150.30%	-53.90%	-59.65%	-64.20%	1.03	8.44	N/A	N/A	N/A
EPRX	EUPRAXIA PHARMACEUTICALS INC	$428.95M	-53.50%	-51.20%	-32.22%	-215.30%	0.07	19.30	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$528.60M	N/A	-21.40%	-27.15%	-33.50%	-0.03	9.06	100.00%	-8,131.50%	-8,149.27%
RXST	RXSIGHT INC	$262.87M	-17.00%	-15.10%	-16.83%	-17.40%	0.14	10.20	77.00%	-36.60%	-36.53%
KROS	KEROS THERAPEUTICS INC	$222.06M	-17.00%	-15.80%	-30.16%	-214.50%	0.09	22.62	100.00%	-256.60%	-272.15%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$729.78M	-61.50%	-41.00%	-41.16%	-122.10%	0.12	6.16	N/A	N/A	N/A
MSLE	SATELLOS BIOSCIENCE INC	$148.73M	N/A	N/A	N/A	N/A	0.07	16.48	N/A	N/A	N/A
PCVX	VAXCYTE INC	$6.84B	-32.50%	-29.50%	-30.47%	-33.20%	0.12	7.49	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$310.66M	-35.70%	-29.50%	-36.03%	-465.30%	0.18	12.66	100.00%	-345.00%	-342.41%
CING	CINGULATE INC	$62.93M	-365.20%	-158.50%	-139.27%	-960.40%	0.64	2.55	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$199.53M	-36.60%	-28.40%	-37.28%	-272.80%	0.28	6.31	100.00%	-143.80%	-143.80%
RGNX	REGENXBIO INC	$348.96M	-232.50%	-61.00%	-90.43%	-42.20%	15.22	2.62	68.20%	-330.20%	-278.82%
TYRA	TYRA BIOSCIENCES INC	$1.96B	-42.70%	-39.80%	-33.38%	-55.30%	0.06	20.49	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$155.10M	-86.20%	-38.40%	-68.68%	-3,620.80%	1.63	2.48	100.00%	-333.50%	-322.16%
LENZ	LENZ THERAPEUTICS INC	$235.79M	-46.80%	-43.30%	-43.97%	-52.80%	0.11	10.40	92.90%	-519.30%	-516.91%
TECX	TECTONIC THERAPEUTIC INC	$538.15M	-32.30%	-30.90%	-35.19%	8,093.00%	0.07	18.51	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$1.81B	-64.20%	-48.40%	-54.15%	-64.00%	0.32	6.01	100.00%	-411.40%	-410.31%
TCRX	TSCAN THERAPEUTICS INC	$66.66M	-91.90%	-50.10%	-66.76%	-76.90%	1.08	6.65	100.00%	-1,360.60%	-1,330.19%
EYPT	EYEPOINT INC	$1.07B	-110.50%	-90.20%	-108.21%	-131.50%	0.25	6.66	76.50%	-3,566.60%	-3,563.19%
AARD	AARDVARK THERAPEUTICS INC	$98.39M	-61.70%	-56.30%	-80.32%	-99.60%	0.13	8.06	N/A	N/A	N/A
XNCR	XENCOR INC	$835.58M	-28.80%	-20.50%	-21.41%	-15.70%	0.43	6.57	100.00%	-177.10%	-145.89%
VERA	VERA THERAPEUTICS INC	$2.47B	-74.90%	-60.20%	-62.68%	-71.90%	0.24	13.64	N/A	N/A	N/A
PSTV	PLUS THERAPEUTICS INC	$47.42M	-198.50%	-73.10%	-100.86%	1,062.90%	0.67	2.27	100.00%	-230.20%	-232.81%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	602	+0.98%	-2.57%	-1.90%	-76.05%	18.28x	4.87x	-122.61%	-12.79%	-9.65%	+63.30%	Strong Buy
Diagnostics & Research	55	+0.67%	+2.81%	-8.17%	+10.83%	15.48x	3.33x	-6.63%	+6.21%	+12.47%	+27.83%	Strong Buy
Drug Manufacturers - General	20	+1.56%	+1.86%	+5.32%	+34.81%	35.69x	7.08x	+34.51%	+12.30%	+21.70%	+16.21%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.45%	+0.08%	-0.21%	-29.54%	10.90x	1.56x	+9.35%	+5.09%	+10.99%	+40.37%	Buy
Healthcare Plans	10	-0.67%	-2.56%	+17.39%	-0.56%	26.31x	2.31x	+9.02%	+2.82%	+6.93%	+0.78%	Buy
Health Information Services	53	-0.32%	+2.09%	+1.61%	-27.61%	18.03x	2.95x	-3.94%	+0.71%	+1.12%	+39.60%	Buy
Medical Care Facilities	50	-0.91%	-2.48%	+4.38%	-21.64%	15.15x	4.82x	-49.93%	+6.78%	+15.36%	+22.72%	Buy
Medical Devices	139	+0.14%	+3.57%	-2.51%	-69.30%	23.09x	3.04x	+6.44%	+5.41%	+9.00%	+33.12%	Strong Buy
Medical Distribution	10	+1.07%	+2.30%	-9.07%	+5.35%	22.37x	143.42x	-104.83%	+3.78%	+25.68%	+28.40%	Buy
Medical Instruments & Supplies	55	+0.20%	+3.38%	-1.50%	-5.73%	42.68x	3.27x	+7.01%	+7.29%	+10.77%	+27.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 42.55% over the past year, overperforming other healthcare stocks by 102 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 57.98% from Bioventus's current stock price of $9.50.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 7 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 122.45% over the past year, overperforming other healthcare stocks by 181 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $251.09, an upside of 4.88% from Jazz Pharmaceuticals's current stock price of $239.40.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 72.73% have issued a Strong Buy rating, 27.27% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 234.79% over the past year, overperforming other healthcare stocks by 294 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 28.14% from Indivior Pharmaceuticals's current stock price of $37.46.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 75 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

Cryo Cell International's dividend payout ratio of -45.5% indicates that its dividend yield might not be sustainable for the long-term.

2. So Young International (NASDAQ:SY)

So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 30.19%, which is 28 percentage points higher than the healthcare sector average of 2.66%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.58% in the last day, and up 0.01% over the last week. Akari Therapeutics was the among the top gainers in the healthcare sector, gaining 255.45% yesterday.

Akari Therapeutics shares are trading higher after the company announced preclinical data demonstrating synergistic activity of AKTX-101 with KRAS inhibition in KRAS-mutated pancreatic cancer models

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -68.4% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 532.26% in the past year. It has overperformed other stocks in the healthcare sector by 591 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 43, which is 28 points higher than the healthcare sector average of 15. It passed 3 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -36.8% in the past year. It has overperformed other stocks in the healthcare sector by 22 percentage points.

Are healthcare stocks a good buy now?

60.49% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.89% over the next year.

4.95% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.38% of healthcare stocks are rated B (Buy), 48.14% are rated C (Hold), 27.48% are rated D (Sell), and 7.05% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.